1 Gunderson JG, Weinberg I, Choi-Kain LW. Borderline personality disorder. Focus. 2013;11(2):129–45.
2 Kernberg OF, Michels R. Borderline personality disorder. Am J Psychiatry. 2009;166(5):505–8.
3 Gunderson JG. The emergence of a generalist model to meet public health needs for patients with borderline personality disorder. Am J Psychiatry. 2016 May 1;173(5):452–8.
4 Coid J, Yang M, Tyrer P, Roberts A, Ullrich S. Prevalence and correlates of personality disorder in Great Britain. Brit J Psychiatry. 2006 May 2;188(5):423–31.
5 Trull TJ, Jahng S, Tomko RL, Wood PK, Sher KJ. Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Pers Disord. 2010 Aug 11;24(4):412–26. doi: 10.1521/pedi.2010.24.4.412. PubMed PMID: 20695803; PubMed Central PMCID: PMC3771514.
6 Volkert J, Gablonski TC, Rabung S, editors. A systematic review and meta-analysis on the prevalence of personality disorders in the general adult population in western countries. 15th International Society for the Study of Personality Disorders (ISSPD); 2017 Sep 25–28; Heidelberg, Germany.
7 Herpertz SC. Beitrag der Neurobiologie zum Verstandnis der Borderline-Personlichkeitsstorung. Nervenarzt. 2011 Jan;82(1):9–15. Epub 2011/01/12. doi: 10.1007/s00115-010-3127-0. PubMed PMID: 21221523.
8 Chanen AM, Kaess M. Developmental pathways to borderline personality disorder. Curr Psychiat Rep. 2012 Feb;14(1):45–53. Epub 2011 Oct 20. doi: 10.1007/s11920-011-0242-y. PubMed PMID: 22009682.
9 Grant BF, Chou SP, Goldstein RB, Huang B, Stinson FS, Saha TD, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2008 Apr 23;69(7):1033–45.
10 Gunderson JG. Disturbed relationships as a phenotype for borderline personality disorder. Am J Psychiatry. 2007 Nov 3;164(11):1637–40.
11 Leichsenring F, Leibing E, Kruse J, New AS, Leweke F. Borderline personality disorder. Lancet. 2011;377(9759):74–84.
12 Walter M, Gunderson JG, Zanarini MC, Sanislow CA, Grilo CM, McGlashan TH, et al. New onsets of substance use disorders in borderline personality disorder over 7 years of follow-ups: Findings from the Collaborative Longitudinal Personality Disorders Study. Addiction. 2009;104(1):97–103.
13 Euler S, Sollberger D, Bader K, Lang UE, Walter M. Persönlichkeitsstörungen und Sucht: Systematische Literaturübersicht zu Epidemiologie, Verlauf und Behandlung. Fortschr Neurol Psychiatr. 2015;83(10):544–54.
14 Ross S, Dermatis H, Levounis P, Galanter M. A comparison between dually diagnosed inpatients with and without Axis II comorbidity and the relationship to treatment outcome. Am J Drug Alcohol Abuse. 2003;29(2):263–79.
15 Walter M, Euler S, Sollberger D. Persönlichkeitsstörungen und Sucht. Stuttgart: Kohlhammer; 2016.
16 Chanen AM, Sharp C, Hoffman P. Prevention and early intervention for borderline personality disorder: a novel public health priority. World Psychiatry. 2017 Jun;16(2):215-6. Epub 2017 May 13. doi: 10.1002/wps.20429. PubMed PMID: 28498598; PubMed Central PMCID: PMC5428197.
17 Sharp C, Fonagy P. Practitioner Review: borderline personality disorder in adolescence - recent conceptualization, intervention, and implications for clinical practice. J Child Psychol Psychiatry. 2015 Dec;56(12):1266–88.
18 Biskin RS. The lifetime course of borderline personality disorder. Can J Psychiatry. 2015 Jul 1;60(7):303-8. doi: 10.1177/070674371506000702. PubMed PMID: 26175388; PubMed Central PMCID: PMC4500179.
19 Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Time to attainment of recovery from borderline personality disorder and stability of recovery: a 10-year prospective follow-up study. Am J Psychiatry. 2010 Jun 1;167(6):663-7. doi: 10.1176/appi.ajp.2009.09081130. PubMed PMID: 20395399; PubMed Central PMCID: PMC3203735.
20 Frankenburg FR, Zanarini MC. The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization. J Clin Psychiatry. 2004 Dec;65(12):1660–5.
21 Hopwood CJ, Zanarini MC. Borderline personality traits and disorder: predicting prospective patient functioning. J Consult Clin Psychol. 2010 Aug;78(4):585-9. doi: 10.1037/a0019003. PubMed PMID: 20658814; PubMed Central PMCID: PMC3203729.
22 Choi-Kain LW, Zanarini MC, Frankenburg FR, Fitzmaurice GM, Reich DB. A longitudinal study of the 10-year course of interpersonal features in borderline personality disorder. J Pers Disord. 2010 Jun 16;24(3):365-76. doi: 10.1521/pedi.2010.24.3.365. PubMed PMID: 20545500; PubMed Central PMCID: PMC3222950.
23 Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice GM. Fluidity of the subsyndromal phenomenology of borderline personality disorder over 16 years of prospective follow-up. Am J Psychiatry. 2016 Jul 1;173(7):688-94. Epub Feb 13. doi: 10.1176/appi.ajp.2015.15081045. PubMed PMID: 26869248; PubMed Central PMCID: PMC4930411.
24 Bohus M, Doering S, Schmitz B, Herpertz SC. Allgemeine Prinzipien in der Psychotherapie von Persönlichkeitsstörungen. Psychother Psychosom Med Psychol. 2009 Apr 8;59(3/4):149–57.
25 Bateman A, Gunderson J, Mulder R. Treatment of personality disorder. Lancet. 2015 Feb 21;385(9969):735-43.
26 Sollberger D, Walter M. Psychotherapie der Borderline-Persönlichkeitsstörung: Gemeinsamkeiten und Differenzen evidenzbasierter störungsspezifischer Behandlungen. Fortschr Neurol Psychiatr. 2010 Dec 8;78(12):698–708.
27 NICE. Borderline personality disorder: the nice guideline on treatment and management. London: The British Psychological Society; 2009.
28 AWMF. S2-Leitlinien für Persönlichkeitsstörungen. DGPPN, editor. Heidelberg: Steinkopff; 2013.
29 DHA. National clinical guideline for the treatment of emotionally unstable personality disorder, borderline type. Copenhagen: Danish Health Authority; 2016.
30 Bohus M, Kroger C. Psychopathologie und psychotherapie der borderline-persönlichkeitsstörung. Nervenarzt. 2011 Jan 12;82(1):16–24.
31 Bohus M, Schmahl C, Herpertz SC, Lieb K, Berger M, Roepke S, et al. Leitliniengerechte stationäre psychiatrisch-psychotherapeutische Behandlung der Borderline-Persönlichkeitsstörung. Nervenarzt. 2016 Jul;87(7):739-45. Epub 2016 Jun 9.
32 Chanen AM. Borderline personality disorder in young people: are we there yet? J Clin Psychol. 2015 Aug;71(8):778-91. Epub 2015 Jul 21.
33 Euler S, Dammann G, Endtner K, Leihener F, Perroud NA, Reisch T et al. Behandlungsempfehlungen zu Borderline-Persönlichkeitsstörung. Schweizerische Gesellschaft für Psychiatrie und Psychotherapie Behandlungsempfehlungen. 2018 Mar [zitiert 28. Juni 2018]: 66 Seiten Verfügbar auf: https://www.psychiatrie.ch/sgpp/fachleute-und-kommissionen/behandlungsempfehlungen/.
34 WHO. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.
35 APA. Diagnostic and statistical manual of mental disorders (DSM-5®). Washington, D. C.: American Psychiatric Pub; 2013.
36 Mulder RT, Horwood J, Tyrer P, Carter J, Joyce PR. Validating the proposed ICD-11 domains. Personal Ment Health. 2016 May;10(2):84–95. Epub 2016 Apr 28.
37 Herpertz SC, Huprich SK, Bohus M, Chanen A, Goodman M, Mehlum L, et al. The challenge of transforming the diagnostic system of personality disorders. J Pers Disord. 2017 Oct;31(5):577–89. Epub 2017 Sep 15.
38 First MB, Gibbon M, Spitzer RL, Benjamin LS. User’s guide for the structured clinical interview for DSM-IV axis II personality disorders: SCID-II. Washington, D.C.: American Psychiatric Press; 1997.
39 Fydrich T, Renneberg B, Schmitz B, Wittchen H. Strukturiertes Klinisches Interview für DSM-IV. Achse II: Persönlichkeitsstörungen (SKID-II). Hogrefe: Göttingen; 1997.
40 Loranger AW, Janca A, Sartorius N. Assessment and diagnosis of personality disorders: the ICD-10 international personality disorder examination (IPDE). Cambridge: Cambridge University Press; 1997.
41 Mombour W, Zaudig M, Berger P, Gutierrez K, Berner W, Berger K, et al. International Personality Disorder Examination (IPDE). Göttingen: Hogrefe; 1996.
42 Loranger AW, Sartorius N, Andreoli A, Berger P, Buchheim P, Channabasavanna SM, et al. The international personality disorder examination: the world health organization/alcohol, drug abuse, and mental health administration international pilot study of personality disorders. Arch Gen Psychiatry. 1994;51(3):215–24.
43 Krueger RF, Derringer J, Markon KE, Watson D, Skodol AE. Initial construction of a maladaptive personality trait model and inventory for DSM-5. Psychol Med. 2012;42(9):1879–90.
44 Zimmermann J, Altenstein D, Krieger T, Holtforth MG, Pretsch J, Alexopoulos J, et al. The structure and correlates of self-reported DSM-5 maladaptive personality traits: findings from two German-speaking samples. J Pers Disord. 2014;28(4):518–40.
45 Bohus M, Kleindienst N, Limberger MF, Stieglitz RD, Domsalla M, Chapman AL, et al. The short version of the Borderline Symptom List (BSL-23): development and initial data on psychometric properties. Psychopathol. 2009;42(1):32–9.
46 Bohus M, Limberger MF, Frank U, Chapman AL, Kühler T, Stieglitz RD. Psychometric properties of the Borderline Symptom List (BSL). Psychopathol. 2007;40(2):126–32.
47 Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale. J Psychopathol Behav. 2004;26(1):41–54.
48 Dan-Glauser ES, Scherer KR. The Difficulties in Emotion Regulation Scale (DERS). Swiss J Psychol. 2013;72(1):5–11.
49 Schwenkmezger P, Hodapp V. A questionnaire for assessing anger and expression of anger. Z Klin Psychol Psychopathol Psychother. 1991;39(1):63-8.
50 Hartmann AS, Rief W, Hilbert A. Psychometric properties of the German Version of the Barratt Impulsiveness Scale, version 11 (Bis–11) for adolescents. Percept Mot Skills. 2011;112(2):353–68.
51 Zimmermann J, Benecke C, Horz-Sagstetter S, Dammann G. Normierung der deutschsprachigen 16-Item-Version des Inventars der Personlichkeitsorganisation (IPO-16). Z Psychosom Med Psychother. 2015 Apr 4;61(1):5–18.
52 Horowitz LM, Strauß B, Kordy H. Inventar zur Erfassung interpersonaler Probleme - Deutsche Version (Testmappe): 2. überarbeitete und neunormierte Auflage. Weinheim: Beltz; 2000.
53 Staun L. Mentalisieren bei Depressionen. 1 ed. Stuttgart: Klett-Cotta; 2017.
54 Gunderson JG, Links PS. Handbook of good psychiatric management (GPM) for borderline patients. Washington, D.C.: American Psychiatric Press; 2014.
55 Links PS, Ross J, Gunderson JG. Promoting good psychiatric management for patients with borderline personality disorder. J Clin Psychol. 2015;71(8):753–63.
56 Livesley WJ. Integrated treatment: a conceptual framework for an evidence-based approach to the treatment of personality disorder. J Pers Disord. 2012 Feb;26(1):17-42. Epub 2012 Mar 1.
57 Bateman A, Krawitz R. Borderline personality disorder: an evidence-based guide for generalist mental health professionals. Oxford: Oxford University Press; 2016.
58 Livesley WJ. Integrated modular treatment for borderline personality disorder: a practical guide to combining effective treatment methods. Cambridge: Cambridge University Press; 2017.
59 Choi-Kain LW, Albert EB, Gunderson JG. Evidence-based treatments for borderline personality disorder: implementation, integration, and stepped care. Harv Rev Psychiatry. 2016 Sep 8;24(5):342–56.
60 Winnicott DW. Playing and Reality. London: Tavistock Publications; 1971.
61 Linehan MM, Davison GC, Lynch TR, Sanderson C. Technique factors in treating personality disorder. In: Castonguay LG, Beutler LE, editors. Principles of therapeutic change that work Oxford: Oxford University Press; 2006. p. 239–52.
62 Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatry. 2009;166(12):1355–64.
63 McMain SF, Guimond T, Streiner DL, Cardish RJ, Links PS. Dialectical behavior therapy compared with general psychiatric management for borderline personality disorder: clinical outcomes and functioning over a 2-year follow-up. Am J Psychiatry. 2012 Jun;169(6):650-61. Epub 2012 May 15. doi: 10.1176/appi.ajp.2012.11091416. PubMed PMID: 22581157.
64 McMain SF, Links PS, Gnam WH, Guimond T, Cardish RJ, Korman L, et al. A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. Am J Psychiatry. 2009;166(12):1365–74.
65 Choi-Kain LW, Finch EF, Masland SR, Jenkins JA, Unruh BT. What works in the treatment of borderline personality disorder. Curr Behav Neurosci Rep. 2017 Mar 24;4(1):21-30. doi: 10.1007/s40473-017-0103-z. PubMed PMID: 28331780; PubMed Central PMCID: PMC5340835.
66 Bateman A, Fonagy P. 8-year follow-up of patients treated for borderline personality disorder: mentalization-based treatment versus treatment as usual. Am J Psychiatry. 2008 May;165(5):631-8. Epub 2008 Apr 19.
67 Herpertz SC, Rudolf G, Lieb K. Borderline-Persönlichkeitsstörungen. In: Herpertz S, Caspar F, Lieb K, editors. Psychotherapie – Funktions- und störungsorientiertes Vorgehen. München: Elsevier; 2017. p. 395–412.
68 Portwich POW. Die Arzt-Patient-Beziehung im Fokus: Was Michael Balint uns heute noch zu sagen hat. Schweiz Arch Neurol Psychiatr. 2014;165(1):4–9.
69 Giesen-Bloo J, Van Dyck R, Spinhoven P, Van Tilburg W, Dirksen C, Van Asselt T, et al. Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry. 2006;63(6):649–58.
70 Davidson KM, Tran CF. Impact of treatment intensity on suicidal behavior and depression in borderline personality disorder: a critical review. J Pers Disord. 2014 Apr;28(2):181–97. Epub 2013 Jun 26.
71 Links PS, Shah R, Eynan R. Psychotherapy for borderline personality disorder: progress and remaining challenges. Curr Psychiat Rep. 2017 Mar 9;19(3):1–16.
72 Linehan MM. Skills training manual for treating borderline personality disorder. New York: Guilford Press; 1993.
73 Linehan MM, Wilks CR. The course and evolution of dialectical behavior therapy. Am J Psychother. 2015;69(2):97–110.
74 Karterud S. Mentalization-Based Group Therapy (MBT-G): A theoretical, clinical, and research manual. Oxford: Oxford University Press; 2015.
75 Farrell JM, Shaw IA. Schematherapie in Gruppen-Therapiemanual für die Borderline-Persönlichkeitsstörung. Weinheim: Beltz; 2013.
76 Bohus M, Bathruff H. Dialektisch Behaviorale Therapie der Borderline-Störung im stationären Setting. PiD. 2000;1(04):55–66.
77 Agarwalla PA, Küchenhoff J, Sollberger D, Gremaud-Heitz DJ, Riemenschneider A, Walter M, et al. Ist die stationäre störungsspezifische Behandlung von Borderline-Patienten einer herkömmlichen psychiatrischen/ psychotherapeutischen stationären Behandlung überlegen. Schweiz Arch Neurol Psychiatr Psychol. 2013;164(6):194–205.
78 Dammann G, Riemenschneider A, Walter M, Sollberger D, Küchenhoff J, Gündel H, et al. Impact of interpersonal problems in borderline personality disorder inpatients on treatment outcome and psychopathology. Psychopathol. 2016;49(3):172– 80.
79 Bohus M, Haaf B, Simms T, Limberger MF, Schmahl C, Unckel C, et al. Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: a controlled trial. Behav Res Ther. 2004 May;42(5):487-99. Epub 2004 Mar 23.
80 Bloom JM, Woodward EN, Susmaras T, Pantalone DW. Use of dialectical behavior therapy in inpatient treatment of borderline personality disorder: a systematic review. Psychiat Serv. 2012;63(9):881–8.
81 Sollberger D, Gremaud-Heitz D, Riemenschneider A, Agarwalla P, Benecke C, Schwald O, et al. Change in identity diffusion and psychopathology in a specialized inpatient treatment for borderline personality disorder. Clin Psychol Psychother. 2015;22(6):559–69.
82 Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry. 1999;156(10):1563–9.
83 Bales D, van Beek N, Smits M, Willemsen S, Busschbach JJ, Verheul R, et al. Treatment outcome of 18-month, day hospital mentalization-based treatment (MBT) in patients with severe borderline personality disorder in the Netherlands. J Pers Disord. 2012;26(4):568–82.
84 Reiss N, Lieb K, Arntz A, Shaw IA, Farrell J. Responding to the treatment challenge of patients with severe BPD: results of three pilot studies of inpatient schema therapy. Behav Cogn Psychother. 2014;42(3):355–67.
85 Bolm T, Herzog T. Mentalisierungsbasierte Behandlung schwerer Borderline-Persönlichkeitsstörungen und Traumafolgen in der Klinik für Psychosomatische Medizin und Fachpsychotherapie, Christophsbad Göppingen. In: Dulz B, Martius P, Fabian E, editors. Stationäre Psychotherapie der Borderline-Störungen in Deutschland. Stuttgart: Schattauer; 2009. p. 91–8.
86 Euler S, Walter M. Mentalisierungsbasierte Psychotherapie (MBT). Freyberger H, Rosner R, Siedler GH, Stieglitz R, Strauss B, editors. Stuttgart: Kohlhammer; 2018.
87 Dammann G, Dulz B, Lohmer M, Kernberg OF. Borderline-Störung. Stationäre psychodynamische Therapie - TFP-Manual. Göttingen: Hofrege; 2017.
88 Farrell JM, Reiss N, Shaw IA. The schema therapy clinician’s guide – a complete resource for building and delivering individual, group and integrated schema mode treatment programs. Sussex: Wiley; 2014.
89 Forster C, Berthollier N, Rawlinson D. A systematic review of potential mechanisms of change in psychotherapeutic interventions for personality disorder. J Psychol Psychother. 2014 Feb 20;4(133).
90 Barnicot K, Katsakou C, Bhatti N, Savill M, Fearns N, Priebe S. Factors predicting the outcome of psychotherapy for borderline personality disorder: a systematic review. Clin Psychol Rev. 2012 Jul;32(5):400-12. Epub 2012 Jun 12.
91 Fonagy P, Bateman A. Mechanisms of change in mentalization-based treatment of BPD. J Clin Psychol. 2006;62(4):411–30.
92 Sharp C, Kalpakci A. Mentalization in borderline personality disorder: from bench to bedside. Personal Disord. 2015 Oct 6;6(4):347–55.
93 Fonagy P, Luyten P, Bateman A. Translation: mentalizing as treatment target in borderline personality disorder. Personal Disord. 2015 Oct 6;6(4):380–92.
94 Chapman AL, Dixon-Gordon KL. Mentalization as a common process in treatments for borderline personality disorder: commentary on the special issue on mentalization in borderline personality disorder. Personal Disord. 2015 Oct 6;6(4):393-4.
95 Kramer U. Personality, personality disorders, and the process of change. Psychother Res. 2017:1-13. Epub Sep 25. doi: 10.1080/10503307.2017.1377358. PubMed PMID: 28946789.
96 Lana F, Fernández-San Martín M. To what extent are specific psychotherapies for borderline personality disorders efficacious? A systematic review of published randomised controlled trials. Actas Esp Psiquiatr. 2013;41(4):242–52.
97 Stoffers JM, Vollm BA, Rucker G, Timmer A, Huband N, Lieb K. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2012 Aug 15;15(8):CD005652. Epub 2012 Aug 17. doi: 10.1002/14651858.CD005652.pub2. PubMed PMID: 22895952.
98 Cristea IA, Gentili C, Cotet CD, Palomba D, Barbui C, Cuijpers P. Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiatry. 2017 Apr 1;74(4):319-28. Epub 2017 Mar 2.
99 Linehan MM. Cognitive-behavioral treatment of borderline personality disorder. New York: Guilford Press; 1993.
100 Bateman A, Fonagy P. Psychotherapy for borderline personality disorder: mentalization based treatment. Oxford: Oxford University Press 2004.
101 Yeomans FE, Clarkin JF, Kernberg OF. A primer of transference-focused psychotherapy for the borderline patient. Lanham: Rowman and Littlefield Pub; 2002.
102 Young JE, Klosko JS, Weishaar ME. Schema therapy: a practitioner’s guide. New York: Guilford Press; 2003.
103 Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry. 1991;48(12):1060–4.
104 Linehan MM, Comtois KA, Murray AM, Brown MZ, Gallop RJ, Heard HL, et al. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry. 2006;63(7):757–66.
105 Verheul R, Van Den Bosch LM, Koeter MW, De Ridder MA, Stijnen T, Van Den Brink W. Dialectical behaviour therapy for women with borderline personality disorder. Br J Psychiatry. 2003;182(2):135–40.
106 Jorgensen CR, Freund C, Boye R, Jordet H, Andersen D, Kjolbye M. Outcome of mentalization-based and supportive psychotherapy in patients with borderline personality disorder: a randomized trial. Acta Psychiatr Scand. 2013 Apr;127(4):305-17. Epub 2012 Aug 18.
107 Doering S, Hörz S, Rentrop M, Fischer-Kern M, Schuster P, Benecke C, et al. Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial. Br J Psychiatry. 2010;196(5):389–95.
108 Clarkin JF, Levy KN, Lenzenweger MF, Kernberg OF. Evaluating three treatments for borderline personality disorder: a multiwave study. Am J Psychiatry. 2007;164(6):922–8.
109 Yeomans FE. Questions concerning the randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry. 2007 May 9;64(5):609–10.
110 Van Asselt AD, Dirksen CD, Arntz A, Giesen-Bloo JH, van Dyck R, Spinhoven P, et al. Out-patient psychotherapy for borderline personality disorder: cost-effectiveness of schema-focused therapy v. transference-focused psychotherapy. Brit J Psychiatry. 2008 Jun 3;192(6):450–7.
111 Farrell JM, Shaw IA, Webber MA. A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: a randomized controlled trial. J Behav Ther Exp Psychiatry. 2009;40(2):317–28.
112 Blum N, St John D, Pfohl B, Stuart S, McCormick B, Allen J, et al. Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with borderline personality disorder: a randomized controlled trial and 1-year follow-up. Am J Psychiatry. 2008 Apr;165(4):468-78. Epub 2008 Feb 19. doi: 10.1176/appi.ajp.2007.07071079. PubMed PMID: 18281407; PubMed Central PMCID: PMC3608469.
113 Streeck U. Die psychoanalytisch-interaktionnelle Therapiemethode. In: Dulz B, Herpertz SC, Kernberg OF, Sachsse U, editors. Handbuch der Borderline-Störungen 2ed. Stuttgart: Schattauer; 2011. p. 576–83.
114 Benjamin LS. Diagnosis and treatment of mental disorders. New York: Guilford Press; 1993.
115 Rudolf G. Strukturbezogene Psychotherapie: Leitfaden zur psychodynamischen Therapie struktureller Störungen. 3 ed. Stuttgart: Schattauer; 2013.
116 Ryle A, Kerr IB. Introducing cognitive analytic therapy: principles and practice. Chichester: John Wiley & Sons; 2003.
117 Breil J, Sachse R. Klärungsorientierte Verhaltenstherapie bei Borderline Persönlichkeitsstörung. In: Dulz B, Herpertz SC, Kernberg OF, Sachsse U, editors. Handbuch der Borderline-Störungen. Stuttgart: Schattauer; 2011. p. 652–66.
118 Pos AE, Greenberg LS. Organizing awareness and increasing emotion regulation: revising chair work in emotion-focused therapy for borderline personality disorder. J Pers Disord. 2012;26(1):84–107.
119 Morton J, Snowdon S, Gopold M, Guymer E. Acceptance and commitment therapy group treatment for symptoms of borderline personality disorder: a public sector pilot study. Cogn Behav Pract. 2012;19(4):527–44.
120 Gregory RJ, DeLucia-Deranja E, Mogle JA. Dynamic deconstructive psychotherapy versus optimized community care for borderline personality disorder co-occurring with alcohol use disorders: a 30-month follow-up. J Nerv Ment Dis. 2010;198(4):
92–8.
121 Høglend P, Hersoug AG, Bøgwald KP, Amlo S, Marble A, Sørbye Ø, et al. Effects of transference work in the context of therapeutic alliance and quality of object relations. J Consult Clin Psychol. 2011;79(5):697–706.
122 Cottraux J, Note ID, Boutitie F, Milliery M, Genouihlac V, Yao SN, et al. Cognitive therapy versus Rogerian supportive therapy in borderline personality disorder. Psychother Psychosom. 2009;78(5):307–16.
123 Davidson KM, Tyrer P, Tata P, Cooke D, Gumley A, Ford I, et al. Cognitive behaviour therapy for violent men with antisocial personality disorder in the community: an exploratory randomized controlled trial. Psychol Med. 2009;39(4):569–77.
124 Emmelkamp PMG, Benner A, Kuipers A, Feiertag GA, Koster HC, Van Apeldoorn FJ. Comparison of brief dynamic and cognitive-behavioural therapies in avoidant personality disorder. Br J Psychiatry. 2006;189(1):60–4.
125 Kramer U, Kolly S, Berthoud L, Keller S, Preisig M, Caspar F, et al. Effects of motive-oriented therapeutic relationship in a ten-session general psychiatric treatment of borderline personality disorder: a randomized controlled trial. Psychother Psychosom. 2014;83(3):176–86.
126 Caspar F, Berger T. Allgemeine Psychotherapie. In: Dulz B, Herpertz SC, Kernberg OF, Sachsse U, editors. Handbuch der Borderline-Störungen. 2 ed. Stuttgart: Schattauer; 2011. p. 667–89.
127 Bohus M, Herpertz SC, Falkai P. Modulare Psychotherapie – Rationale und Grundprinzipien. Psychiatrie. 2012;9(2):89–97.
128 Livesley WJ, Dimaggio G, Clarkin JF. Integrated treatment for personality disorder: a modular approach. New York: Guilford Publications; 2015.
129 Edel MA, Raaff V, Dimaggio G, Buchheim A, Brüne M. Exploring the effectiveness of combined mentalization-based group therapy and dialectical behaviour therapy for inpatients with borderline personality disorder: a pilot study. Brit J Clin Psychol. 2017;56(1):1–15.
130 Stoffers JM, Lieb K. Pharmacotherapy for borderline personality disorder - current evidence and recent trends. Curr Psychiat Rep. 2015 Nov 21;17(1):534.
131 Zanarini MC, Frankenburg FR, Reich DB, Conkey LC, Fitzmaurice GM. Treatment rates for patients with borderline personality disorder and other personality disorders: a 16-year study. Psychiatr Serv. 2015 Jan 1;66(1):15-20. Epub 2014 Oct 2. doi: 10.1176/appi.ps.201400055. PubMed PMID: 25270039; PubMed Central PMCID: PMC4283568.
132 Martinho E, Fitzmaurice GM, Frankenburg FR, Zanarini MC. Pro re nata (as needed) psychotropic medication use in patients with borderline personality disorder and subjects with other personality disorders over 14 years of prospective follow-up. J Clin Psychopharm. 2014;34(4):499–503.
133 Stoffers JM, Vollm BA, Rucker G, Timmer A, Huband N, Lieb K. Pharmacological interventions for borderline personality disorder. Cochrane Database Syst Rev. 2010 Jun 16(6):CD005653. Epub 2010 Aug 18. doi: 10.1002/14651858.CD005653.pub2. PubMed PMID: 20556762; PubMed Central PMCID: PMC4169794.
134 Ingenhoven TJ. Pharmacotherapy for borderline patients: business as usual or by default? J Clin Psychiatry. 2015 Apr 29;76(4):e522–3.
135 Ingenhoven TJ, Lafay P, Rinne T, Passchier J, Duivenvoorden HJ. Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials. J Psychiat Pract. 2010;17(1):21–34.
136 Mercer D, Douglass AB, Links PS. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. J Pers Disord. 2009;23(2):156–74.
137 Vita A, De Peri L, Sacchetti E. Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials. J Clin Psychopharm. 2011;31(5):613–24.
138 Ripoll LH, Triebwasser J, Siever LJ. Evidence-based pharmacotherapy for personality disorders. Focus. 2013;11(2):225–48.
139 Kahl KG, Greggersen W, Schweiger U, Cordes J, Correll CU, Frieling H, et al. Prevalence of the metabolic syndrome in patients with borderline personality disorder: results from a cross-sectional study. Eur Arch Psy Clin N. 2013;263(3):205–13.
140 Herpertz SC, Zanarini MC, Schulz CS, Siever L, Lieb K, Moller HJ, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World J Biol Psychiatry. 2007 Oct 27;8(4):212–44.
141 Zimmerman M, Rothschild L, Chelminski I. The prevalence of DSM-IV personality disorders in psychiatric outpatients. Am J Psychiatry. 2005;162(10):1911–8.
142 Weinbrecht A, Schulze L, Boettcher J, Renneberg B. Avoidant personality disorder: a current review. Curr Psychiat Rep. 2016 Feb 1;18(3):29.
143 Euler S, Stalujanis E, Spitzer C. Aktueller Stand der Psychotherapie von Persönlichkeitsstörungen. Z Klin Psychol Psychiatr Psychother. in press.
144 Sharp C, Wright AGC, Fowler JC, Frueh BC, Allen JG, Oldham J, et al. The structure of personality pathology: both general (‘g’) and specific (‘s’) factors? J Abnorm Psychol. 2015;124(2):387–98.
145 Silk KR. The quality of depression in borderline personality disorder and the diagnostic process. J Pers Disord. 2010;24(1):25–37.
146 Beatson JA, Rao S. Depression and borderline personality disorder. Med J Aust. 2012;197(11):620–1.
147 Sipos V, Bohus M, Schweiger U. Dialektisch-behaviorale Therapie für Essstörungen (DBT-E). Psychother Psychosom Med Psychol. 2011 Feb 22;61(2):87–91.
148 Choi-Kain LW, Gunderson JG. Borderline personality and mood disorders. New York: Springer; 2016.
149 Stringer B, van Meijel B, Eikelenboom M, Koekkoek B, Licht CM, Kerkhof AJ, et al. Recurrent suicide attempts in patients with depressive and anxiety disorders: the role of borderline personality traits. J Affect Disord. 2013;151(1):23–30.
150 Küchenhoff J. Psychotherapie der Depression. Schweiz Med Forum. 2012;12(12):267–71.
151 Bateman A, Fonagy P. Borderline personality disorder and mood disorders: mentalizing as a framework for integrated treatment. J Clin Psychol. 2015;71(8):792–804.
152 Levenson JC, Wallace ML, Fournier JC, Rucci P, Frank E. The role of personality pathology in depression treatment outcome with psychotherapy and pharmacotherapy. J Consult Clin Psychol. 2012;80(5):719–29.
153 Gunderson JG, Stout RL, Shea MT, Grilo CM, Markowitz JC, Morey LC, et al. Interactions of borderline personality disorder and mood disorders over ten years. J Clin Psychiat. 2014;75(8):829–34.
154 Gunderson JG, Weinberg I, Daversa MT, Kueppenbender KD, Zanarini MC, Shea MT, et al. Descriptive and longitudinal observations on the relationship of borderline personality disorder and bipolar disorder. Am J Psychiatry. 2006;163(7):1173–8.
155 Frías A, Baltasar I, Birmaher B. Comorbidity between bipolar disorder and borderline personality disorder: prevalence, explanatory theories, and clinical impact. J Affect Disord. 2016;202:210-9.
156 Boritz TZ, Barnhart R, McMain SF. The influence of posttraumatic stress disorder on treatment outcomes of patients with borderline personality disorder. J Pers Disord. 2016;30(3):395–407.
157 Harned MS, Korslund KE, Linehan MM. A pilot randomized controlled trial of dialectical behavior therapy with and without the dialectical behavior therapy prolonged exposure protocol for suicidal and self-injuring women with borderline personality disorder and PTSD. Behav Res Ther. 2014;55:7–17.
158 Harned MS, Chapman AL, Dexter-Mazza ET, Murray AM, Comtois KA, Linehan MM. Treating co-occurring axis I disorders in recurrently suicidal women with borderline personality disorder: a 2-year randomized trial of dialectical behavior therapy versus community treatment by experts. Pers Disord Theor Res Treat. 2009;S(1):35–45.
159 Barnicot K, Priebe S. Post-traumatic stress disorder and the outcome of dialectical behaviour therapy for borderline personality disorder. Personal Ment Health. 2013;7(3):181–90.
160 Bohus M, Dyer AS, Priebe K, Krüger A, Kleindienst N, Schmahl C, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013;82(4):221–33.
161 Steuwe C, Rullkötter N, Ertl V, Berg M, Neuner F, Beblo T, et al. Effectiveness and feasibility of Narrative Exposure Therapy (NET) in patients with borderline personality disorder and posttraumatic stress disorder–a pilot study. BMC Psychiatry. 2016;16(254):1–11.
162 Dulz B, Herpertz SC, Sachse R, Kernberg OF. Handbuch der Borderline-Störungen. Stuttgart: Schattauer; 2011.
163 Van Den Bosch LMC, Verheul R. Patients with addiction and personality disorder: treatment outcomes and clinical implications. Curr Opin Psychiatry. 2007;20(1):67–71.
164 Linehan MM, Dimeff LA, Reynolds SK, Comtois KA, Welch SS, Heagerty P, et al. Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug Alcohol Depend. 2002;67(1):13–26.
165 Linehan MM, Schmidt H, Dimeff LA, Craft JC, Kanter J, Comtois KA. Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. Am J Addict. 1999;8(4):
279–92.
166 Ball SA, Cobb-Richardson P, Connolly AJ, Bujosa CT, O’Neall TW. Substance abuse and personality disorders in homeless drop-in center clients: symptom severity and psychotherapy retention in a randomized clinical trial. Comp Psychiat. 2005;46(5):371–9.
167 Ball SA, Maccarelli LM, LaPaglia DM, Ostrowski MJ. Randomized trial of dual-focused versus single-focused individual therapy for personality disorders and substance dependence. J Nerv Ment Dis. 2011;199(5):319–28.
168 Gregory RJ, Remen AL. A manual-based psychodynamic therapy for treatment-resistant borderline personality disorder. Psychother Theor Res Pract Train. 2008;45(1):15–27.
169 Kienast T, Stoffers J, Bermpohl F, Lieb K. Borderline personality disorder and comorbid addiction: epidemiology and treatment. Dtsch Arztebl. 2014;111(16):280–6.
170 Lee NK, Cameron J, Jenner L. A systematic review of interventions or co-occurring substance use and borderline personality disorders. Drug Alcohol Rev. 2015;34(6):663–72.
171 Ralevski E, Ball SA, Nich C, Limoncelli D, Petrakis I. The impact of personality disorders on alcohol-use outcomes in a pharmacotherapy trial for alcohol dependence and comorbid axis I disorders. Am J Addict. 2007;16(6):443–9.
172 Golubchik P, Sever J, Zalsman G, Weizman A. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial. Ind Clin Psychopharm. 2008;23(4):228–31.
173 Prada P, Nicastro R, Zimmermann J, Hasler R, Aubry JM, Perroud N. Addition of methylphenidate to intensive dialectical behaviour therapy for patients suffering from comorbid borderline personality disorder and ADHD: a naturalistic study. ADHD. 2015;7(3):199–209.
174 Chen EY, Matthews L, Allen C, Kuo JR, Linehan MM. Dialectical behavior therapy for clients with binge-eating disorder or bulimia nervosa and borderline personality disorder. Int J Eat Disord. 2008;41(6):505–12.
175 Telch CF, Agras WS, Linehan MM. Dialectical behavior therapy for binge eating disorder. J Consult Clin Psychol. 2001;69(6):1061–5.
176 Robinson P, Barrett B, Bateman A, Hakeem A, Hellier J, Lemonsky F, et al. Study protocol for a randomized controlled trial of mentalization based therapy against specialist supportive clinical management in patients with both eating disorders and symptoms of borderline personality disorder. BMC Psychiatry. 2014;14(51):1–10.
177 Zeeck A, Euler S. Mentalisierungsbasierte Therapie (MBT) für die Behandlung von Essstörungen (MBT-ED) in der Tagesklinik. Behandlungsmanual. Psychotherapeut. in press.
178 Chanen AM, Jovev M, McCutcheon LK, Jackson HJ, McGorry PD. Borderline personality disorder in young people and the prospects for prevention and early intervention. Curr Psychiatry Rev. 2008;4(1):48–57.
179 Schmeck K, Schlüter-Müller S. Persönlichkeitsstörungen im Jugendalter. Heidelberg, Berlin: Springer; 2009.
180 Newton-Howes G, Clark LA, Chanen A. Personality disorder across the life course. Lancet. 2015;385(9969):727–34.
181 Kaess M, Brunner R, Chanen A. Borderline personality disorder in adolescence. Pediatrics. 2014;134(4):782–93.
182 Fonagy P, Speranza M, Luyten P, Kaess M, Hessels C, Bohus M. ESCAP Expert Article: borderline personality disorder in adolescence: an expert research review with implications for clinical practice. Eur Child Adolesc Psychiatry. 2015 Nov;24(11):1307–20. Epub 2015 Aug 15.
183 Tyrer P. The likely classification of borderline personality disorder in adolescents in ICD-11. In: Sharp C, Tackett JL, editors. Handbook of borderline personality disorder in children and adolescents. New York: Springer; 2014. p. 451–7.
184 Chanen AM, Jovev M, Jackson HJ. Adaptive functioning and psychiatric symptoms in adolescents with borderline personality disorder. J Clin Psychiatry. 2007;68(2):297–306.
185 Chanen AM, McCutcheon LK. Prevention and early intervention for borderline personality disorder: current status and recent evidence. Br J Psychiatry. 2013;202(54):24–9.
186 Paris J, Chenard-Poirier MP, Biskin R. Antisocial and borderline personality disorders revisited. Comp Psychiat. 2013 May;54(4):321-5. Epub 2012 Dec 4.
187 Goth K, Schmeck K. AIDA – Assessment of Identity Development in Adolescence. Offenbach: Academic Tests; 2018.
188 Biskin RS. Treatment of borderline personality disorder in youth. J Can Acad Child Adolesc Psychiatry. 2013;22(3):230–4.
189 Newnham EA, Janca A. Childhood adversity and borderline personality disorder: a focus on adolescence. Curr Opin Psychiatry. 2014;27(1):68–72.
190 Seiffge-Krenke I. Psychotherapie und Entwicklungspsychologie. 2. ed. Berlin: Springer; 2004.
191 Fruzzetti AE, Shenk C, Hoffman PD. Family interaction and the development of borderline personality disorder: a transactional model. Dev Psychopathol. 2005;17(4):1007–30.
192 Fleischhaker C, Sixt B, Schulz E. DBT-A: Dialektisch-behaviorale Therapie für Jugendliche: Ein Therapiemanual mit Arbeitsbuch auf CD. Berlin: Springer; 2011.
193 Taubner S, Volkert J. Mentalisierungsbasierte Therapie für Adoleszente (MBT-A). Göttingen: Vandenhoeck & Ruprecht; 2017.
194 Normandin L, Ensink K, Yeomans FE, Kernberg OF. Transference-focused psychotherapy for personality disorders in adolescence. In: Sharp C, Tackett JL, editors. Handbook of borderline personality disorder in children and adolescents. New York: Springer; 2014. p. 333–59.
195 Loose C, Graaf P, Zarbock G. Schematherapie mit Kindern und Jugendlichen. Weinheim: Beltz-Verlag; 2013.
196 Foelsch PA, Schlüter-Müller S, Odom AE, Arena H, Borzutzky A, Schmeck K. Behandlung von Jugendlichen mit Identitätsstörungen (AIT): Ein integratives Therapiekonzept für Persönlichkeitsstörungen. Berlin: Springer; 2013.
197 Schuppert HM, Giesen-Bloo J, van Gemert TG, Wiersema HM, Minderaa RB, Emmelkamp PMG, et al. Effectiveness of an emotion regulation group training for adolescents – a randomized controlled pilot study. Clin Psychol Psychother. 2009;16(6):467–78.
198 Streeck-Fischer A, Cropp C, Streeck U, Salzer ST. Borderline-Störungen bei Jugendlichen: die psychoanalytisch-interaktionelle Methode. Göttingen: Hogrefe; 2016.
199 Fonagy P. The effectiveness of psychodynamic psychotherapies: an update. World Psychiatry. 2015 Jun 5;14(2):137-50. doi: 10.1002/wps.20235. PubMed PMID: 26043322; PubMed Central PMCID: PMC4471961.
200 Schmeck K, Romanos M. Persönlichkeitsstörungen. In: Gerlach M, Mehler-Wex C, Walitza S, Warnke A, Wewetzer C, editors. Neuro-Psychopharmaka im Kindes- und Jugendalter Grundlagen und Therapie. 2 ed. Wien, New York: Springer; 2016. p. 523–37.
201 Mehlum L, Tørmoen AJ, Ramberg M, Haga E, Diep LM, Laberg S, et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior: a randomized trial. J Am Acad Child Adoles Psychiat. 2014;53(10):1082–91.
202 Mehlum L, Ramberg M, Tørmoen AJ, Haga E, Diep LM, Stanley BH, et al. Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. J Am Acad Child Adoles Psychiat. 2016;55(4):295–300.
203 Chanen AM, Jackson HJ, McCutcheon LK, Jovev M, Dudgeon P, Yuen HP, et al. Early intervention for adolescents with borderline personality disorder using cognitive analytic therapy: randomised controlled trial. Br J Psychiatry. 2008;193(6):477–84.
204 Chanen AM, McCutcheon LK, Germano D, Nistico H, Jackson HJ, McGorry PD. The HYPE Clinic: an early intervention service for borderline personality disorder. J Psychiatr Pract. 2009 May 23;15(3):163–72.
205 Schuppert HM, Timmerman ME, Bloo J, van Gemert TG, Wiersema HM, Minderaa RB, et al. Emotion regulation training for adolescents with borderline personality disorder traits: a randomized controlled trial. J Am Acad Child Adoles Psychiat. 2012;51(12):1314–23.
206 Rossouw TI, Fonagy P. Mentalization-based treatment for self-harm in adolescents: a randomized controlledtrial. J Am Acad Child Adoles Psychiat. 2012;51(12):1304–13.
205 Salzer S, Cropp C, Jaeger U, Masuhr O, Streeck-Fischer A. Psychodynamic therapy for adolescents suffering from co-morbid disorders of conduct and emotions in an in-patient setting: a randomized controlled trial. Psychol Med. 2014;44(10):2213–22.